Methods and devices for the integrated discovery of cell culture environments

• US 20030113813A1
• Filed: 09/30/2002
• Published: 06/19/2003
• Est. Priority Date: 11/15/2001
• Status: Abandoned Application

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Meyer, Mary K., Heidaran, Mohammad A., Rowley, Jon A., Hemperly, John J.
• Application Number:
  US10/260,737
• Publication Number:
  US 20030113813A1
• Time in Patent Office: Days
• US Class Current: 435/7.2
• CPC Class Codes: C12M 25/14 Scaffolds; Matrices in general C12N5/0068
• CPC Class Codes: C12M 41/46 of cellular or enzymatic activity or functionality, e.g. cell viability
• CPC Class Codes: C12N 2533/32 Polylysine, polyornithine
• CPC Class Codes: C12N 2533/40 Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
• CPC Class Codes: C12N 2533/74 Alginate
• CPC Class Codes: C12N 5/0654 Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth

Abstract

The present invention is directed to methods and devices which can be used to test bioactive agents alone or in conjunction with 3D scaffolds for their effect on cell growth, differentiation, and other cellular functions.

Claims

1. A cell culture device for assessing the effects of three-dimensional (3D) scaffolds on a desired cellular activity, comprising a culture vessel or support surface in contact with a layer of a cell adhesion resistant (CAR) material that forms a CAR surface, and a plurality of 3D scaffolds in contact with said CAR surface.

2. The device of claim 1 wherein said CAR material is bound irreversibly to said surface.

3. The device of claim 1 wherein said CAR material is bound reversibly to said surface.

4. The device of claim 1 wherein said scaffolds are bound irreversibly to said CAR material.

5. The device of claim 1 wherein said scaffolds are bound reversibly to said CAR material.

6. The device of claim 1, wherein said cell adhesion resistant material is selected from the group consisting of (a) polyethylene glycol, (b) glyme, (c) a glyme derivative, (d) poly-HEMA, (e) polyisopropylacrylamide, (f) hyaluronic acid, (g) alginic acid, (h) a derivative of hyaluronic acid or alginic acid, and (i) a combination of any two or more of (a)-(h).

7. The device of claim 4, wherein said cell adhesion resistant material is hyaluronic acid.

8. The device of claim 1 further comprising an additional layer comprising a reactive material between said support surface and said CAR layer.

9. The device of claim 8, wherein said reactive material is polyethyleneimine, poly-L-lysine, poly-D-lysine, poly-L-ornithine and poly-D-ornithine.

10. The device of claim 1, wherein said bonded CAR material is susceptible to oxidation-mediated chemical activation.

11. The device of claim 1, further comprising a bioactive agent present on or bonded to a surface of said scaffold.

12. The device of claim 11, wherein said bioactive agent comprises an extracellular matrix molecule or a growth factor.

13. The device of claim 12, wherein said extracellular matrix molecule is vitronectin, fibronectin, tenascin, laminin, a collagen, entactin, a proteoglycan, aggrecan, decorin, biglycan, a glycosaminoglycan or Matrigel™

.

14. The device of claim 13, wherein said extracellular matrix molecule is a collagen.

15. The device of claim 12, wherein said bioactive agent is a growth factor.

16. The device of claim 15, wherein said growth factor is a bone morphogenetic protein, epidermal growth factor, erythropoietin, heparin binding factor, hepatocyte growth factor, insulin, insulin-like growth factor I or II (IGF-I, II), an interleukin, a muscle morphogenic protein, nerve growth factor, platelet-derived growth factor or transforming growth factor α

or β

.

17. The device of claim 1, wherein said scaffold comprises a base material selected from the group consisting of (a) a natural polymer, (b) a synthetic polymer, (c) an inorganic composite and (d) any combination of (a)-(c).

18. A kit useful for optimizing a cell culture system cell growth and/or differentiation, comprising

(a) the device of any of claims 1-17, and

(b) packaging material.

19. The kit of claim 18 further comprising:

(c) one or more reagents for use in cell culture and/or for measurement of said cell growth or differentiation.

20. The kit of claim 18 further comprising

(d) instructions for using said system.

21. The kit of claim 19 further comprising

(d) instructions for using said system.

22. A method for designing a culture system that permits or promotes a predetermined amount or level of a cellular activity, and which system optionally enables assessment of said cellular activity, said method comprising;

(a) testing cells for said cellular activity after culture a culture vessel or on a culture surface in the presence of one or more first level combinations of

(i) a candidate culture medium component; and

(ii) a candidate bioactive surface comprising one or more bioactive agents presented to cells in or on one or more 3D scaffolds;

which culture vessel surface and/or scaffold is in contact with a CAR material,

thereby identifying an optimal first level combination of said medium components and said bioactive agents;

(b) selecting said optimal first level combination identified in step (a); and

(c) incorporating said selected optimal first level combination of medium components and bioactive agents into a culture system comprising a culture vessel or surface and one or more 3D scaffolds have therein or thereon said selected optimal first level combination of medium components and bioactive surface,

thereby designing said culture system.

23. The method of claim 22, further comprising:

(d) measuring the ability of said cell culture system to permit or promote said predetermined amount or level of said cellular activity.

24. The method of claim 22, further comprising

(i) testing said cells for said desired activity after culture in the presence of one or more second level combinations of said medium components and said bioactive surface, thereby identifying an optimal second level combination;

(ii) selecting the optimal second level combination, and

(iii) incorporating said selected optimal second level combination of medium components and bioactive agents into a culture system comprising a culture vessel or surface and one or more 3D scaffolds comprising said selected second level combination.

30. The method of claim 22 or 25, wherein said bioactive agent comprises an extracellular matrix molecule or a growth factor.

31. The method of claim 30, wherein said extracellular matrix molecule is vitronectin, fibronectin, tenascin, laminin, a collagen, entactin, a proteoglycan, aggrecan, decorin, biglycan, a glycosaminoglycan or Matrigel™

.

32. The method of claim 31, wherein said collagen is collagen VI.

33. The method of claim 22, wherein said surface is treated with an oxidative plasma prior to creation of said CAR layer.

34. The method of claim 22, further comprising an additional layer comprising a reactive material between said vessel or surface and said CAR layer.

35. The method of claim 34, wherein said reactive material comprises polyethyleneimine, poly-L-lysine, poly-L-lysine, poly-L-ornithine, poly-D-ornithine.

36. The method of any of claims 22 wherein said CAR layer is treated with an oxidizing agent.

37. The method of claim 22 wherein said bioactive agents are deposited onto said CAR layer as a microarray.

38. The method of claim 30 wherein said bioactive agent is a growth factor.

39. The method of claim 22, wherein said scaffold comprises a base material selected from the group consisting of (a) a natural polymer, (b) a synthetic polymer, (c) an inorganic composite and (d) any combination of (a)-(d).

40. The method of claim 39, wherein said scaffold comprises collagen.

41. The method of claim 22 wherein said cellular activity is cell growth or cell differentiation.

42. The method of claim 41 wherein said cell growth or differentiation is measured using a detectably labeled antibody.

25. A method for designing a culture system that permits or promotes a predetermined amount or level of a cellular activity, and which system optionally enables assessment of said cellular activity, said method comprising;

(a) testing cells for said activity after culture in a culture vessel or a culture surface, comprising a plurality of 3D scaffolds, in the presence of one or more combinations of

(i) one or more a bioactive agents bound to one or more CAR materials on said scaffolds, and

(ii) one or more culture medium components,

thereby identifying an optimal combination of CAR material, bioactive agent and medium component;

(b) selecting said optimal combination identified in step (a),

(c) incorporating said selected optimal combination of CAR material, medium component and bioactive agent into a culture system comprising

(i) a culture vessel or surface comprising the CAR material of said combination,

(ii) in contact with said culture vessel or surface, one or more 3D scaffolds having attached thereto the CAR material of said optimal combination

thereby designing said culture system.

26. The method of claim 25 further comprising:

(d) measuring the ability of said cell culture system to permit or promote said predetermined amount or level of said cellular activity.

27. The method of claim 25 wherein said measuring is performed by cell imaging using an imaging apparatus operatively linked to said culture system.

28. The method of claim 25, wherein said CAR material is selected from the group consisting of (a) polyethylene glycol, (b) glyme, (c) a glyme derivative, (d) poly-HEMA, (e) poly-isopropylacrylamide, (f) hyaluronic acid, (g) alginic acid, (h) a derivative of hyaluronic acid or alginic acid, and (i) a combination of any two or more of (a)-(h).

29. The method of claim 28 wherein said CAR material is hyaluronic acid.

43. A method for producing a device for assessing the effects, on a selected cellular activity, of culturing cells in a culture system that comprises a 3D scaffold, said method comprising:

(a) screening bioactive agents bound to a first CAR layer on a first support surface for their effect on said cellular activity by culturing cells in the presence of said agents, and selecting one or more of said agents that have a desired effect on said cellular activity;

(b) depositing said one or more bioactive agents selected in (a onto a 3D scaffold to generate bioactive surfaces on said scaffold; and

(c) depositing a plurality of said scaffolds having said bioactive surfaces onto a second CAR support surface, wherein said first and said second support surfaces comprise either the same or different CAR material.